These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 11422597)
61. Lowering copayments: impact of simvastatin patent expiration on patient adherence. Sedjo RL; Cox ER Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498 [TBL] [Abstract][Full Text] [Related]
62. Analyzing contrasting approaches to drug services. Johnson RE; Campbell WH Med Care; 1974 Jan; 12(1):62-74. PubMed ID: 4811403 [No Abstract] [Full Text] [Related]
63. Strategies for managing prescription drug costs. Stern L Bus Health; 1990 Jun; 8(6):41-2, 44. PubMed ID: 10104793 [No Abstract] [Full Text] [Related]
64. Health care reform and the pharmaceutical industry. Mossinghoff GJ Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353 [TBL] [Abstract][Full Text] [Related]
65. Treating and Preventing HIV with Generic Drugs - Barriers in the United States. Martin EG; Schackman BR N Engl J Med; 2018 Jan; 378(4):316-319. PubMed ID: 29365306 [No Abstract] [Full Text] [Related]
66. Future pharmacists and public initiatives to control retail drug prices: a political economy framework. Pelton LE; Strutton D; Smith MC Health Mark Q; 1993; 10(3-4):241-59. PubMed ID: 10127923 [TBL] [Abstract][Full Text] [Related]
67. The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons. Schicke RK Int J Health Serv; 1973; 3(2):223-36. PubMed ID: 4197751 [No Abstract] [Full Text] [Related]
68. The association of insurance type with costs of dispensed drugs. Mott DA; Kreling DH Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015 [TBL] [Abstract][Full Text] [Related]
70. Patients who pay out-of-pocket receive lower-cost drugs. Am J Health Syst Pharm; 1998 Aug; 55(15):1556-8. PubMed ID: 9706178 [No Abstract] [Full Text] [Related]
71. Employers push to manage prescription drug costs. Frieden J Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119 [No Abstract] [Full Text] [Related]
72. Generic boost. Bill, acquisitions could help hospitals save money. Rhea S Mod Healthc; 2009 Apr; 39(16):17. PubMed ID: 19419134 [No Abstract] [Full Text] [Related]
73. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1. Kuhrt K; Chace-Ortiz M IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217 [TBL] [Abstract][Full Text] [Related]
74. What's at stake. Gordon JR; Maule CJ CPJ; 1989 Feb; 122(2):74-6, 78. PubMed ID: 10292087 [No Abstract] [Full Text] [Related]
75. Prior authorization made easier. Terry K Med Econ; 2007 Oct; 84(20):34, 38, 40. PubMed ID: 18075056 [No Abstract] [Full Text] [Related]
76. The state and consequences of dermatology drug prices in the United States. Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978 [No Abstract] [Full Text] [Related]
77. Justifying high drug prices within the context of value: Biologics versus generics. Patterson ME; Rosenfelt DJ Res Social Adm Pharm; 2018 Feb; 14(2):121-123. PubMed ID: 28259587 [No Abstract] [Full Text] [Related]
79. Generics prices in SA compare well with those in other countries. S Afr Med J; 2005 Feb; 95(2):88. PubMed ID: 15751196 [No Abstract] [Full Text] [Related]
80. 24th annual prescription survey, Albany College of Pharmacy. DeNuzzo RV Med Mark Media; 1980 Apr; 15(4):17-36. PubMed ID: 10245963 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]